« Back
Home /
Anti-Transferrin Receptor/TFRC Antibody (PE), Mouse Monoclonal

Anti-Transferrin Receptor/TFRC Antibody (PE), Mouse Monoclonal

Manufacturer	Sino Biological
Category	Oncology Neuroscience Targets for Rodent Neurosciences Antibodies By Cell Type Hematology Leukemia Flow Cytometry Primary Antibodies
Type	Antibody Monoclonal
Specific against	Human
Clone	03
Isotype	IgG1
Applications	FC
Amount	100Tests
Host	Mouse
Item no.	11020-MM03-P-100
eClass 6.1	32160702
eClass 9.0	42030590
Available
Antigen molecule name	TFRC
Storage	This antibody is stable for 12 months from date of receipt when stored at 2C-8C. Protected from prolonged exposure to light. Do not freeze ! Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
Immunogen	Recombinant Human Transferrin Receptor / TFRC / CD71 Protein (Catalog#11020-H07H)
Purification	Protein A
Conjugate	PE
Preparation	This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Transferrin Receptor / TFRC / CD71 (rh Transferrin Receptor / TFRC / CD71; Catalog#11020-H07H; NP_003225.2; Cys89-Phe760) and conjugated with PE under optimum conditions, the unreacted PE was removed.
Specificity	Human Transferrin Receptor / TFRC / CD71
Buffer	Aqueous solution containing 0.5% BSA and 0.09% sodium azide
Concentration	10 ul/Test, 0.1 mg/ml

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

11020-MM03-P-100-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100Tests

available

Delivery expected until 5/23/2024